G&M Health, LLC – Trademark Portfolio
Entity Type: 16
G&M Health, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include STAT, SHALL, TRACKIT, PHARMA CLASSES, and SHERLO AUDITOR. The owner is based in Somerset, NJ.
285 Davidson Avenue, Suite 103
Somerset, NJ 08873
Showing of trademarks Trademarks
Trademark Classifications
G&M Health, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does G&M Health, LLC have?
G&M Health, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 8 registered.
What trademark classes does G&M Health, LLC file in?
G&M Health, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 35 (Advertising & Business), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are G&M Health, LLC's most well-known trademarks?
G&M Health, LLC's registered trademark portfolio includes well-known marks such as STAT, SHALL, TRACKIT, PHARMA CLASSES, and SHERLO AUDITOR. These are among 8 currently registered trademarks in the portfolio.
What is G&M Health, LLC's trademark registration success rate?
G&M Health, LLC has a 100% trademark registration rate, with 8 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.